Loading…
Bipartisan Budget Act of 2015
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
94pct
243d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
(This measure has not been amended since the Senate agreed to the House amendment to the Senate amendment on October 30, 2015. The summary of that version is repeated here.) Bipartisan Budget Act of 2015 TITLE I--BUDGET ENFORCEMENT (Sec. 101) This bill amends the Balanced Budget and Emergency Deficit Control Act of 1985 to increase the discretionary spending limits for FY2016 and FY2017. The bill revises procedures for implementing the sequester of direct spending, which is required under current law and involves cuts that interact with discretionary spending levels. The bill requires the sequester to take place in FY2016 and FY2017 as if the amendments that this bill makes to the discretionary spending limits have not been made. It also adds an additional year to the sequester in FY2025 and adjusts the cuts required for Medicare. (Direct spending, also known as mandatory spending, is spending provided by laws other than appropriations bills. Sequestration is a process of automatic, usually across-the-board spending reductions under which budgetary resources are permanently cancelled to enforce specific budget policy goals.) The bill requires the discretionary spending limits in FY2016 and FY2017 to be increased by specified amounts for overseas contingency operations. (Sec. 102) The chairman of the Senate Budget Committee must file for publication in the Congressional Record committee allocations, aggregate spending and revenue levels, and levels of revenues and outlays for Social Security consistent with this bill. The chairman may also include reserve funds contained in the FY2016 budget resolution that are extended by one year. The bill provides that the allocations, aggregates, and levels submitted by the chairman are enforceable in the Senate as if they were included in a budget resolution conference agreement. The provisions in this section expire if Congress agrees to a budget resolution for FY2017. TITLE II--AGRICULTURE (Sec. 201) The bill amends the Federal Crop Insurance Act to require the Department of Agriculture (USDA) to renegotiate the Standard Reinsurance Agreement no later than December 31, 2016, and at least once every five years thereafter. (The Standard Reinsurance Agreement is an agreement between USDA and the private companies that administer the federal crop insurance program. It specifies details such as administrative and operating expense reimbursements and risk sharing between USDA and the companies in the operation of the program.) The bill establishes an 8.9% cap on the overall rate of return for insurance providers under the agreement, which is a decrease from the current negotiated rate of approximately 14.5%. TITLE III--COMMERCE (Sec. 301) The bill amends the Communications Act of 1934 to authorize the use of automated telephone equipment to call cellular telephones for the purpose of collecting debts owed to the U.S. government. The Federal Communications Commission must issue regulations implementing this section within nine months of enactment of this bill. The regulations may restrict the number and duration of the calls. TITLE IV--STRATEGIC PETROLEUM RESERVE (Sec. 401) The Energy Policy and Conservation Act is amended to revise the requirement that the Department of Energy (DOE) transmit a detailed explanation to Congress regarding a test drawdown and sale or exchange of petroleum products from the Strategic Petroleum Reserve (SPR). DOE shall notify Congress of the test at least 14 days before the date on which it is conducted, unless an emergency requires the test, in which case DOE must notify Congress as soon as possible. The detailed description of the test DOE is currently required to submit to Congress must be submitted within 180 days after completion of the test. The term "severe energy supply interruption" shall now include a national energy supply shortage resulting, or is likely to result, from an act of terrorism. (Sec. 402) DOE shall within 180 days after enactment of this Act: complete a long-range strategic review of the SPR and submit to Congress a proposed action plan and implementation schedule specifying both near- and long-term roles of the SPR relative to U.S. energy and economic security; describe whether existing legal authorities governing SPR policies, configuration, and capabilities are adequate to ensure that the SPR can meet current and future U.S. energy and economic security objectives; identify SPR configuration and performance capabilities; recommend an action plan to achieve the optimal capacity, location, and composition of SPR petroleum products in addition to storage and distributional capabilities; and estimate the resources required to attain and maintain SPR long-term sustainability and operational effectiveness. (Sec. 403) For each of FY2018-FY2025 DOE shall draw down and sell from the SPR specified barrels of crude oil ranging from 5 million (FY2018) to 10 million barrels (FY2025). DOE shall not, however, draw down and sell crude oil in amounts that would limit presidential authority to sell the full amount of petroleum products authorized when necessary to prevent or reduce the adverse impact of severe domestic energy supply interruptions. (Sec. 404) There is established in the Treasury the Energy Security and Infrastructure Modernization Fund for the deposit of SPR crude oil sales proceeds to provide for the construction, maintenance, repair, and replacement of SPR facilities. To protect the U.S. economy from the impacts of emergency product supply disruptions, DOE shall establish an SPR modernization program, for which appropriations are authorized for FY2017-2020. DOE authority to draw down and sell crude oil from the SPR under this section shall expire at the end of FY2020. TITLE V--PENSIONS (Sec. 501) This section amends the Employee Retirement Income Security Act of 1974 (ERISA) to increase the annual fixed rate premium payable to the Pension Benefits Guaranty Corporation by a single-employer plan for basic benefits to $69 in plan years beginning in 2017, $74 in plan years beginning in 2018, and $80 in plan years beginning after 2018. The variable rate premium for such plans increases by an additional $3 for plan years beginning in 2017 and by an additional $4 for plan years beginning in 2018 and 2019. (Sec. 502) This section changes the due date for premium payments for plan years beginning in 2025 to the 15th day of the 9th calendar month beginning on or after the 1st day of the premium payment year. (Sec. 503) This section changes criteria for mortality tables used by defined benefit pension plans for plan years beginning after 2015. The determination of whether a plan has credible mortality information shall be made in accordance with established actuarial credibility theory, which is materially different from current mortality rules under ERISA and Revenue Procedure 2007-37. A plan may use mortality tables that are adjusted from tables provided by the Department of the Treasury if such adjustments are based on a plan's experience. (Sec. 504) This section amends the Internal Revenue Code and ERISA to adjust interest rates used to calculate minimum funding contributions to pension plans The tables provide for adjustments to interest rates so that they fall within a range based on average interest rates over a 25-year period. For plan years beginning after 2015, the range variance is 10% through 2020, 15% in 2021, 20% in 2022, 25% in 2023, and 30% in 2024 and subsequent plan years. TITLE VI--HEALTH CARE (Sec. 601) The bill amends title XVIII (Medicare) of the Social Security Act (SSAct) to: (1) mitigate 2016 increases to Medicare Part B premiums and deductibles for enrollees, and (2) authorize federal funding to offset the corresponding reduction in aggregate monthly premiums. Under current law, the Centers for Medicare & Medicaid Services must annually determine the monthly actuarial rate upon which Part B premiums and deductibles are based. For 2016, the bill revises this methodology, effectively reducing increases to premiums and deductibles for certain enrollees in 2016. (Current law already protects Part B enrollees whose benefits are deducted from their Social Security benefits from premium increases that would result in a smaller net benefit from Social Security.) This methodology shall also apply in 2017 if, as in 2016, there is no increase in monthly Social Security benefits. (Sec. 602) The bill amends title XIX (Medicaid) of the SSAct to require manufacturers of generic drugs to join manufacturers of single-source or innovator drugs in paying rebates to state Medicaid programs for price increases over inflation. (Sec. 603) The bill excludes certain hospital outpatient department services from the prospective payment system in which predetermined amounts form the basis for payment under Medicare. With specified exceptions, services are excluded from this system if they are furnished by a provider's off-campus outpatient department. (Sec. 604) The bill amends the Fair Labor Standards Act of 1938 to repeal the requirement, established under the Patient Protection and Affordable Care Act, for large employers offering health benefit plans to automatically enroll full-time employees in such a plan. A large employer is one that has more than 200 full-time employees. TITLE VII--JUDICIARY Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015 (Sec. 701) This title amends the Federal Civil Penalties Inflation Adjustment Act of 1990 to require federal agencies that impose civil monetary penalties subject to inflation adjustments under the Adjustment Act to adjust the penalties for inflation annually instead of at least every four years. The categories of penalties required to be adjusted for inflation under the Adjustment Act are expanded to include civil penalties under the Occupational Safety and Health Act of 1970 and the Social Security Act. For all civil penalties adjusted for inflation under the Adjustment Act, federal agencies must make an initial adjustment after enactment of this bill by the percentage by which the Consumer Price Index (CPI) for October 2015 exceeds the CPI for the month of October of the calendar year during which the amount of such civil monetary penalty was established or adjusted under a provision of law other than this bill. The increase in penalties from the initial adjustment is prohibited from exceeding 150% of the amount of that penalty on the date of enactment of this bill. An agency may adjust penalties by less than the required amount under an exception that applies to the first adjustment if: (1) the agency determines in a rulemaking with an opportunity for public comment that the adjustment would have a negative economic impact or social costs that outweigh the benefits, and (2) the Office of Management and Budget (OMB) concurs. The annual inflation adjustment in subsequent years must be a cost-of-living adjustment based on any increases in the October CPI each year. Inflation adjustment increases must be rounded to the nearest multiple of $1. This section also requires: (1) the OMB to issue guidance to agencies regarding the implementation of adjustments, (2) agencies to include information about adjustments to civil monetary penalties in agency financial reports, and (3) the Government Accountability Office to submit an annual report assessing agency compliance. (Sec. 702) This section rescinds and permanently cancels $1.5 billion of the funds deposited or available in the Crime Victims Fund under the Victims of Crime Act of 1984. (Sec. 703) This section rescinds and permanently cancels $746 million of the amounts deposited in the Department of Justice Assets Forfeiture Fund. TITLE VIII--SOCIAL SECURITY Social Security Benefit Protection and Opportunity Enhancement Act of 2015 Subtitle A--Ensuring Correct Payments and Reducing Fraud (Sec. 811) The Social Security Administration (SSA) must expand Cooperative Disability Investigations (CDI) Units that investigate suspected fraud before benefits are awarded to cover all 50 States, the District of Columbia, Puerto Rico, Guam, the Northern Mariana Islands, the Virgin Islands, and American Samoa. (Sec. 812) Title II (Old Age, Survivors and Disability Insurance) of the Social Security Act is amended to prohibit evidence submitted by unlicensed or sanctioned physicians and health care providers from being considered in making disability determinations. (Sec. 813) A new felony for conspiracy to commit Social Security fraud is created. Penalties for individuals in a position of trust who defraud the SSA are increased. Individuals are disqualified from receiving benefits during a trial work period if they are assessed a civil monetary penalty for concealing work activity. (Sec. 814) Prohibitions and penalties regarding the misuse of symbols, emblems, and names associated with Social Security and Medicare are applied to electronic and internet communications, and each internet viewing is treated as a separate offense. (Sec. 815) The Balanced Budget and Emergency Deficit Control Act of 1985 is amended to revise the permissible uses and amounts of adjustments to discretionary spending limits for program integrity spending. The permissible uses are expanded to include CDI units, Special Assistant U.S. Attorneys who prosecute Social Security fraud, and work-related continuing disability reviews. Subtitle B--Promoting Opportunity for Disability Beneficiaries (Sec. 821) The authority for Disability Insurance (DI) demonstration projects is extended through 2021 and all projects must be terminated by the end of 2022. (Sec. 822) The authority for DI demonstration projects is modified to: (1) revise congressional reporting and review requirements, and (2) require participation in the projects to be voluntary and include informed consent. (Sec. 823) The SSA must carry out a pilot program to test the effect on beneficiary earnings of changes in how earnings are treated for the purpose of ongoing DI benefit eligibility. Under the demonstration, the existing "cash cliff" under which beneficiaries lose their entire benefit after exceeding the earnings threshold would be replaced by a benefit offset under which the DI benefit is reduced by $1 for every $2 of earnings in excess of a threshold. (Sec. 824) The SSA may obtain, with beneficiary consent, data on beneficiary earnings from payroll providers through a data exchange. Individuals for whom the SSA obtains earnings data from these sources are exempt from the requirement to report their own earnings. (Sec. 825) The SSA may simplify the process of evaluating a beneficiary's earnings derived from services by presuming that wages and salaries were earned in: (1) the month in which the services were performed for making a determination of initial entitlement on the basis of disability, and (2) the month in which the earnings were paid for any other purpose. These presumptions apply unless information is available that shows when the income was earned. (Sec. 826) The SSA must permit DI beneficiaries to report their earnings electronically, including by telephone and Internet, based on the system that is currently available to Supplemental Security Income recipients. Subtitle C--Protecting Social Security Benefits (Sec. 831) Provisions in the Social Security Act related to deemed filing, dual entitlement, and benefit suspension are amended to prevent individuals from obtaining larger benefits than Congress intended. (Sec. 832) In making an initial determination of disability, the SSA must make every reasonable effort to ensure that a qualified physician, psychiatrist, or psychologist has completed the medical portion of the case review. (Sec. 833) Specified payroll tax revenues are reallocated to the Disability Insurance Trust Fund to pay benefits until 2022. (Sec. 834) The SSA may verify certain financial information when an individual requests a waiver of an overpayment because they are without fault and unable to repay the funds. Subtitle D--Relieving Administrative Burdens and Miscellaneous Provisions (Sec. 841) Under current law, the Office of Personnel Management (OPM) must reduce disability payments made to a Federal Employment Retirement (FERS) annuitant who also receives Social Security disability benefits. The bill increases interagency coordination by permitting SSA to repay the OPM the amount of overpaid FERS benefits if the individual is eligible for DI and entitled to an award of past-due benefits. The overpaid amounts are deducted from the past-due Social Security payment. (Sec. 842) The requirement that the SSA make determinations every five years relating to wage credits for military service prior to 1957 is eliminated after the 2010 determination. (Sec. 843) Electronic certification to the Railroad Retirement Board is permitted for benefits payable to a divorced spouse of a railroad worker. (Sec. 844) Technical and conforming changes are made to eliminate obsolete provisions from the Social Security Act. (Sec. 845) The SSA must report to Congress on: (1) fraud prevention activities and improper payments, (2) work-related continuing disability reviews, and (3) overpayment waivers. (Sec. 846) The SSA may request that OPM hold additional examinations for the purpose of hiring Administrative Law Judges as needed. TITLE IX--TEMPORARY EXTENSION OF PUBLIC DEBT LIMIT (Sec. 901) The public debt limit is suspended through March 15, 2017. On March 16, 2017, the limit is increased to accommodate obligations issued during the suspension period. (Sec. 902) Adjustments to the debt limit for obligations during the suspension period are limited to obligations necessary to fund a commitment incurred by the federal government that required payment before March 16, 2017. The Department of the Treasury may not issue obligations during the suspension period to increase cash balances above normal operating balances. TITLE X--SPECTRUM PIPELINE Spectrum Pipeline Act of 2015 (Sec. 1004) This title requires the Department of Commerce to submit to the President and to the Federal Communications Commission (FCC) a report identifying 30 megahertz of electromagnetic spectrum to reallocate from federal use to: (1) nonfederal use, (2) shared federal and nonfederal use, or (3) a combination of such uses. The President must then withdraw or modify the assignment to a federal government station of the identified spectrum. By July 1, 2024, the FCC must begin competitive bidding auctions to grant new initial licenses for that spectrum. (Sec. 1005) The National Telecommunications and Information Administration Organization Act is amended to make amounts available from the Spectrum Relocation Fund for the Office of Management and Budget (OMB) to pay federal entities for research and development activities to improve the efficiency and effectiveness of their spectrum use in order to make additional frequencies available for auction. As a condition to the OMB paying a federal entity for such activities, the federal entity must have a plan: (1) approved by a technical panel within the National Telecommunications and Information Administration (NTIA), and (2) submitted by the OMB to the appropriate congressional committees for a period of 60 days. (Sec. 1006) The FCC must coordinate with the NTIA to submit successive proposals to Congress by 2022 and by 2024 that identify additional spectrum to be assigned new licenses for nonfederal use. Each proposal must identify at least another 50 megahertz. (Sec. 1007) For purposes of auctioning the 30 megahertz that Commerce identifies under this Act, the FCC's authority to grant licenses or permits is extended until September 30, 2025. The FCC's authority continues to expire on September 30, 2022, for other competitive bidding auctions. (Sec. 1008) The FCC must submit to Congress, within three years after enactment of this Act, reports that analyze: (1) rules changes relating to frequencies between 3550 and 3650 megahertz, and (2) proposals to promote and identify additional spectrum bands that can be shared between incumbent uses and new licensed and unlicensed services under such rules. The FCC must also identify at least 1 gigahertz within a specified range for such use. TITLE XI--REVENUE PROVISIONS RELATED TO TAX COMPLIANCE (Sec. 1101) This section amends the Internal Revenue Code to revise rules for audits of large for-profit partnerships (partnerships with more than 100 partners). Existing audit rules for such partnerships are repealed and partnerships with fewer than 100 partners are granted an election to opt out of the provisions of this Act. The new audit rules require that: (1) any adjustment to items of partnership income, gain, loss, deductions, or credits be determined at the partnership level, instead of for each individual partner; (2) each partner's return be consistent with the partnership return; (3) each partnership designate a partner or other person with a substantial presence in the United States as the partnership representative to act as the sole authority on behalf of the partnership; and (4) notice be given to the partnership and the partnership representative of any administrative proceeding initiated at the partnership level, of any proposed partnership adjustment resulting from such proceeding, and of any final partnership adjustment resulting from such proceeding. The partnership may file a petition for readjustment of any partnership item within 90 days after the date on which a notice of a final partnership adjustment is mailed to the partnership. The petition may be filed with the U.S. Tax Court, a U.S. district court for the district in which the partnership's principal place of business is located, or the U.S. Court of Claims. The period for making adjustments to a partnership return is limited to the date that is three years (six years in the case of a substantial omission of income) after the latest of the date on which the partnership return was filed, the return due date for the taxable year, or the date on which the partnership filed an administrative adjustment request. No limit applies in the case of a false or fraudulent partnership return or if no return is filed. (Sec. 1102) This section sets forth a rule with respect to partnership interests created by gift to provide that in the case of a capital interest in a partnership in which capital is a material income-producing factor, the determination of whether a person is a partner with respect to such interest is made without regard to whether such interest was derived by gift from any other person. This new rule applies to partnership taxable years beginning on or after January 1, 2015. TITLE XII--DESIGNATION OF SMALL HOUSE ROTUNDA This title designates the first floor of the area of the House of Representatives wing of the U.S. Capitol known as the small House rotunda as the "Freedom Foyer."
Yes
431
No
258
Present
0
Not Voting
11
Party Breakdown
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (307)
Became Public Law No: 114-74.
Became Public Law No: 114-74.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Message on Senate action sent to the House.
Senate agreed to the House amendment to the Senate amendment to H.R. 1314 by Yea-Nay Vote. 64 - 35. Record Vote Number: 294. (consideration: CR S7674-7675)
SenateResolving differences -- Senate actions: Senate agreed to the House amendment to the Senate amendment to H.R. 1314 by Yea-Nay Vote. 64 - 35. Record Vote Number: 294.(consideration: CR S7674-7675)
SenateMotion to waive all applicable budgetary discipline with respect to the measure agreed to in Senate by Yea-Nay Vote. 64 - 35. Record Vote Number: 293. (consideration: CR S7674)
Bills with similar content found using semantic analysis.
Sources: Congress.gov · House Clerk roll-call votes
| #293 | senate | On the Motion | Motion Agreed to (64-35, 3/5 majority required) | October 30, 2015 |
| #292 | senate | On the Cloture Motion | Cloture Motion Agreed to (63-35, 3/5 majority required) | October 30, 2015 |
| #294 | senate | On the Motion | Motion Agreed to (64-35) | October 30, 2015 |
| #193 | senate | On Passage of the Bill | Bill Passed (62-37) | May 22, 2015 |
| #192 | senate | On the Cloture Motion | Cloture Motion Agreed to (61-38, 3/5 majority required) | May 22, 2015 |
| #180 | senate | On Cloture on the Motion to Proceed | Cloture on the Motion to Proceed Agreed to (65-33, 3/5 majority required) | May 14, 2015 |
| #176 | senate | On Cloture on the Motion to Proceed | Cloture on the Motion to Proceed Rejected (52-45, 3/5 majority required) | May 12, 2015 |
2020 · third_quarter · Aviation/Airlines/Airports
H.R. 7616 - Transportation-HUD and Related Agencies Appropriations Act, 2021, provisions relating to the funding of the Administration's budget request for air traffic control modernization. H.R. 3475, S. 1968 - Spectrum NOW Act provisions related to Spectrum Efficient National Surveillance Radar (SENSR). Spectrum auction issues to amend the Spectrum Pipeline Act of 2015 (H.R. 1314 -Sec 1004). H.R. 5119 - The Safe Aircraft Maintenance Standards Act on Foreign Repair Stations, all provisions. H.R. 8408 - To direct the Administrator of the Federal Aviation Administration to require certain safety standards relating to aircraft, and for other purposes., provisions related to FAA Certifications. H.R. 6800 - The Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), provisions related to Return to Flight. S.3969 - Aircraft Safety and Certification Reform Act of 2020, provisions related to aviation safety. General issues related to Aviation Research Funding.
Client expense: $1,820,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense Security Cooperation Agency (DSCA), Defense, Dept of (DOD), Director of National Intelligence (ODNI), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Aeronautics & Space Administration (NASA), Natl Oceanic & Atmospheric Administration (NOAA), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office
2020 · fourth_quarter · Aviation/Airlines/Airports
H.R. 7616 - Transportation-HUD and Related Agencies Appropriations Act, 2021, provisions relating to the funding of the Administration's budget request for air traffic control modernization. H.R. 3475, S. 1968 - Spectrum NOW Act provisions related to Spectrum Efficient National Surveillance Radar (SENSR). Spectrum auction issues to amend the Spectrum Pipeline Act of 2015 (H.R. 1314 -Sec 1004). H.R. 5119 - The Safe Aircraft Maintenance Standards Act on Foreign Repair Stations, provisions related foreign repair stations. H.R. 8408 - To direct the Administrator of the Federal Aviation Administration to require certain safety standards relating to aircraft, and for other purposes., provisions related to FAA certifications, modernization and reform. H.R. 6800 - The Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), provisions related to Return to Flight. S.3969 - Aircraft Safety and Certification Reform Act of 2020, provisions related to aviation safety and FAA modernization and reform. General issues related to Aviation Research Funding.
Client expense: $2,140,000 · Firm income: Not reported
2020 · third_quarter · Aviation/Airlines/Airports
H.R. 7616 - Transportation-HUD and Related Agencies Appropriations Act, 2021, provisions relating to the funding of the Administration's budget request for air traffic control modernization. H.R. 3475, S. 1968 - Spectrum NOW Act provisions related to Spectrum Efficient National Surveillance Radar (SENSR). Spectrum auction issues to amend the Spectrum Pipeline Act of 2015 (H.R. 1314 -Sec 1004). H.R. 5119 - The Safe Aircraft Maintenance Standards Act on Foreign Repair Stations, all provisions. H.R. 8408 - To direct the Administrator of the Federal Aviation Administration to require certain safety standards relating to aircraft, and for other purposes., provisions related to FAA Certifications. H.R. 6800 - The Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), provisions related to Return to Flight. S.3969 - Aircraft Safety and Certification Reform Act of 2020, provisions related to aviation safety. General issues related to Aviation Research Funding.
Client expense: $2,170,000 · Firm income: Not reported
2020 · second_quarter · Aviation/Airlines/Airports
FY21 Transportation-HUD and Related Agencies Appropriations (Bills Pending), provisions relating to the funding of the Administration's budget request for air traffic control modernization. H.R. 3475, S. 1968 - Spectrum NOW Act provisions related to Spectrum Efficient National Surveillance Radar (SENSR). Spectrum auction issues to amend the Spectrum Pipeline Act of 2015 (H.R. 1314 -Sec 1004). H.R. 5119 - The Safe Aircraft Maintenance Standards Act on Foreign Repair Stations, all provisions. H.R. 748 - Coronavirus Aid, Relief, and Economic Security Act (CARES Act); and H.R. 6800 - The Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), provisions related to Return to Flight. S.3969 - Aircraft Safety and Certification Reform Act of 2020, provisions related to aviation safety. General issues related to Aviation Research Funding.
Client expense: $2,460,000 · Firm income: Not reported
2020 · first_quarter · Aviation/Airlines/Airports
FY21 Transportation-HUD and Related Agencies Appropriations (Bills Pending), provisions relating to the funding of the Administration's budget request for air traffic control modernization. Spectrum NOW Act (H.R. 3475,S. 1968), provisions related to Spectrum Efficient National Surveillance Radar (SENSR). Outreach on spectrum auction issues to amend the Spectrum Pipeline Act of 2015 (H.R. 1314 -Sec 1004).
Client expense: $680,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense Security Cooperation Agency (DSCA), Defense, Dept of (DOD), Director of National Intelligence (ODNI), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Aeronautics & Space Administration (NASA), Natl Geospatial Intelligence Agency, Natl Oceanic & Atmospheric Administration (NOAA), Natl Security Agency (NSA), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Point of order that the House message to accompany H.R. 1314 violates S.Con.Res. 11 raised in Senate. (consideration: CR S7674)
Motion by Senator McConnell to refer to Senate Committee on Finance the House message to accompany H.R. 1314 with instructions to report back forthwith with the following amendment (SA 2752) fell when cloture was invoked on the motion to concur in the House amendment to the Senate amendment in Senate. (consideration: CR S7668)
Cloture on the motion to concur in the House amendment to the Senate amendment invoked in Senate by Yea-Nay Vote. 63 - 35. Record Vote Number: 292. (consideration: CR S7668; text: CR S7668)
SenateConsidered by Senate (Message from the House considered). (consideration: CR S7665-7675)
Considered by Senate (Message from the House considered). (consideration: CR S7604-7621, S7622-7624, S7625-7643, S7643-7652)
Motion by Senator McConnell to refer to Senate Committee on Finance the House message to accompany H.R. 1314 with instructions to report back forthwith with the following amendment (SA 2752) made in Senate. (consideration: CR S7586)
Motion by Senator McConnell to concur in the House amendment to the Senate amendment with an amendment (SA 2750) made in Senate. (consideration: CR S7585)
Cloture motion on the motion to concur in the House amendment to the Senate amendment presented in Senate. (consideration: CR S7585; text: CR S7585)
Motion by Senator McConnell to concur in the House amendment to the Senate amendment made in Senate. (consideration: CR S7585)
Measure laid before Senate by unanimous consent. (consideration: CR S7585-7586)
Message on House action received in Senate and at desk: House amendment to Senate amendment.
Motion to reconsider laid on the table Agreed to without objection.
On motion that the House agree with an amendment to the Senate amendment Agreed to by the Yeas and Nays: 266 - 167 (Roll No. 579). (text as House agreed to Senate amendment with amendment: CR H7273-7302)
HouseResolving differences -- House actions: On motion that the House agree with an amendment to the Senate amendment Agreed to by the Yeas and Nays: 266 - 167 (Roll No. 579).(text as House agreed to Senate amendment with amendment: CR H7273-7302)
HouseThe previous question was ordered pursuant to the rule. (consideration: CR H7312)
DEBATE - The House proceeded with one hour of debate on the Rogers (KY) motion that the House concur in the Senate amendment to H.R. 1314 with an amendment printed in part A of House Report 114-315 modified by the amendment printed in part B.
Pursuant to the provisions of H. Res. 495, Mr. Rogers (KY) moved to concur in the Senate amendment to H.R. 1314 with an amendment. (consideration: CR H7273-7312)
The Chair recongized Mr. Rogers (KY) for a motion.
Rule H. Res. 495 passed House.
Rules Committee Resolution H. Res. 495 Reported to House. Rule provides for consideration of H.R. 1314 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions. Measure will be considered read. The resolution provides for consideration of the Senate amendment to H.R. 1314.
TABLING MOTION TO CONCUR - The Chair announced that, without objection, the pending motion to reconsider the vote on the question of concurring in that portion of the Senate amendment to H.R. 1314 comprising title II (except for section 212) is laid upon the table.
On motion to concur in portion of Senate amendment preceding title II Agreed to by recorded vote: 219 - 211 (Roll no. 362). (consideration: CR H4334-4335)
HouseMOTION TO RECONSIDER - Mr. Boehner moved to reconsider the vote by which the portion of the Senate amendment comprising title II (except for section 212) was rejected. The Chair put the question on the motion to reconsider and by voice vote, announced that the ayes had prevailed. Mr. Levin demanded a recorded vote and the Chair postponed further proceedings on the motion to reconsider until a time to be announced.
On motion to concur in portion of Senate adt comprising title II (except sec 212) Failed by recorded vote: 126 - 302 (Roll no. 361). (consideration: CR H4333-4334)
HouseThe previous question was ordered pursuant to the rule. (consideration: CR H4333)
Pursuant to the provisions of H. Res. 305, the Chair announced that the question of concurring in the Senate amendment to H.R. 1314 would be divided into portions and the questions on each portion would be put as follows: (1) Concurring in that portion of the Senate amendment comprising title II (except section 212); and (2) concurring in that portion of the Senate amendment comprising the remaider of title II.
Considered as unfinished business. (consideration: CR H4265-4271, H4333-4335)
POSTPONED PROCEEDINGS - Pursuant to clause 1(c) of Rule 19, further proceedings on the Ryan (WI) motion to concur in Senate amendment to H.R. 1314 were postponed.
DEBATE - The House resumed debate on the Ryan (WI) motion to agree to the Senate amendment to H.R. 1314.
DEBATE - Pursuant to the provisions of H. Res. 305, the House proceeded with one hour of debate on the Ryan (WI) motion to concur in the Senate amendment to H.R. 1314. At the conclusion of debate on the Ryan (WI) motion to concur in the Senate amendment to H.R. 1314 and pursuant to the provisions of H.Res. 305, the question will be divided.
Mr. Ryan (WI) moved that the House agree to the Senate amendment. (consideration: CR H4247-4265; text of Senate amendment as received in House: CR H4247-4261)
Message on Senate action sent to the House.
Passed Senate with an amendment by Yea-Nay Vote. 62 - 37. Record Vote Number: 193.
SenatePassed/agreed to in Senate: Passed Senate with an amendment by Yea-Nay Vote. 62 - 37. Record Vote Number: 193.
SenateCloture on the measure invoked in Senate by Yea-Nay Vote. 61 - 38. Record Vote Number: 192. (consideration: CR S3295-3296; text: CR S3295)
SenateConsidered by Senate. (consideration: CR S3256-3259, S3265-3267, S3267-3269, S3274, S3280-3283, S3290-3298)
Considered by Senate. (consideration: CR S3202-3207, S3209-3212, S3225-2231)
Considered by Senate. (consideration: CR S3092-3175)
Cloture motion on the measure presented in Senate. (consideration: CR S3052; text: CR S3052)
Considered by Senate. (consideration: CR S3015-3024, S3024-3053)
Considered by Senate. (consideration: CR S2951-2968)
Measure laid before Senate by motion. (consideration: CR S2926-2927)
Motion to proceed to consideration of measure agreed to in Senate by Unanimous Consent. (consideration: CR S2914-2926)
Upon reconsideration, cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 65 - 33. Record Vote Number: 180. (consideration: CR S2912-2913; text: CR S2912)
SenateMotion by Senator McConnell to reconsider the vote by which cloture on the motion to proceed to the measure was not invoked (Roll Call Vote No. 176) agreed to in Senate by Unanimous Consent. (consideration: CR S2912)
Motion to proceed to consideration of the motion to reconsider the vote by which cloture was not invoked on the motion to proceed to the measure (Record Vote No. 176) agreed to in Senate by Unanimous Consent. (consideration: CR S2908-2912)
Motion to proceed to measure considered in Senate. (consideration: CR S2792)
Motion to proceed to consideration of measure made in Senate. (consideration: CR S2787-2792)
Motion by Senator McConnell to reconsider the vote by which cloture on the motion to proceed to the measure was not invoked (Record Vote No. 176) entered in Senate. (consideration: CR S2787)
Cloture on the motion to proceed to the measure not invoked in Senate by Yea-Nay Vote. 52 - 45. Record Vote Number: 176. (consideration: CR S2786-2787; text: CR S2786)
SenateCloture motion on the motion to proceed to the measure presented in Senate. (consideration: CR S2699, S2726; text: CR S2699)
Motion to proceed to consideration of measure made in Senate.
Motion to proceed to consideration of measure made in Senate. (consideration: CR S2663)
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 58.
Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2235)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2235)
DEBATE - The House proceeded with forty minutes of debate on H.R. 1314.
Considered under suspension of the rules. (consideration: CR H2235-2236)
Mr. Ryan (WI) moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 47.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 114-67.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the House Committee on Ways and Means.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| April 20, 2015 |
| Engrossed in House | April 15, 2015 |
| Reported in House | April 13, 2015 |
| Introduced in House | March 4, 2015 |
| Enrolled Bill | -- |
| S 1005 |
114th |
| Related bill |
| S 1003 | 114th | Related bill |
| HRES 495 | 114th | Procedurally-related |
| HRES 305 | 114th | Related bill |
| HR 2146 | 114th | Related bill |
| HR 2029 | 114th | Related bill |
| HR 1892 | 114th | Related bill |
| HR 1890 | 114th | Related bill |
Government targets: Commerce, Dept of (DOC), Defense Security Cooperation Agency (DSCA), Defense, Dept of (DOD), Director of National Intelligence (ODNI), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Aeronautics & Space Administration (NASA), Natl Oceanic & Atmospheric Administration (NOAA), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Government targets: Commerce, Dept of (DOC), Defense Security Cooperation Agency (DSCA), Defense, Dept of (DOD), Director of National Intelligence (ODNI), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Aeronautics & Space Administration (NASA), Natl Oceanic & Atmospheric Administration (NOAA), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Government targets: Commerce, Dept of (DOC), Defense Security Cooperation Agency (DSCA), Defense, Dept of (DOD), Director of National Intelligence (ODNI), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Aeronautics & Space Administration (NASA), Natl Oceanic & Atmospheric Administration (NOAA), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office
2018 · second_quarter · Trade (domestic/foreign)
Trans-Pacific Partnership H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act of 2015 H.R. 1314 Trade Act of 2015 PHIT Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Trade (domestic/foreign)
Trans-Pacific Partnership H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act of 2015 H.R. 1314 Trade Act of 2015 PHIT Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Pharmacy
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2051: FAST Generics Act of 2017. S.124: Preserve Access to Affordable Generics Act. H.R.1245/S.469: Affordable and Safe Prescription Drug Importation Act. H.R.1314: Bipartisan Budget Act of 2015. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). H.R.2562/S.1115: Making Pharmaceutical Markets More Competitive Act. S.771: Improving Access To Affordable Prescription Drugs Act. Pharmaceutical Exclusivity. H.R.2212/S.974: CREATES Act of 2017. H.R.2439/S.1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017. S.297: Increasing Competition in Pharmaceuticals Act. H.R.749: Lower Drug Costs through Competition Act. H.R.2430/S.934: FDA Reauthorization Act of 2017. H.R.1223/S.1509: Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017.
Client expense: $1,290,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2017 · fourth_quarter · Medicare/Medicaid
Preventing cuts to Medicare Graduate Medical Education payments; preventing cuts to Disproportionate Share Hospital Payments: "The Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015" (H.R. 3288); Preventing reductions to Hospital Inpatient and Outpatient PPS Payments: "The Medicare Crosswalk Hospital Code Development Act of 2015" (H.R. 3291), Medicare payments for Off-Campus Hospital outpatient departments; implementation of Section 603 "Bipartisan Budget Act of 2015)" (H.R. 1314), "Helping Hospitals Improve Patient Care Act of 2016" (H.R. 5273) 21st Century Cures Act (H.R. 34); Additional Medicare support for Medicare Graduate Medical Education; Medicare payment for short hospital stays; Preventing reductions to the Medicaid program including the provider tax; Improvements to the Medicaid program for medically complex children.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · fourth_quarter · Trade (domestic/foreign)
Trans-Pacific Partnership H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act of 2015 H.R. 1314 Trade Act of 2015 PHIT Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Trade (domestic/foreign)
H.R.1314 - Trade Act of 2015 United States-Japan beef issues, no specific legislation United States-Korea beef issues, no specific legislation United States-China beef and pork issues, no specific legislation United States-Taiwan beef and pork issues, no specific legislation United States-Russia pork issues, no specific legislation United States-Mexico beef and pork issues, no specific legislation United States-European Union beef issues, no specific legislation Trans-Pacific Partnership negotiations, no specific legislation
Client expense: Not reported · Firm income: $50,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2017 · third_quarter · Pharmacy
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2051: FAST Generics Act of 2017. S.124: Preserve Access to Affordable Generics Act. H.R.1245/S.469: Affordable and Safe Prescription Drug Importation Act. H.R.1314: Bipartisan Budget Act of 2015. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). H.R.2562/S.1115: Making Pharmaceutical Markets More Competitive Act. S.771: Improving Access To Affordable Prescription Drugs Act. Pharmaceutical Exclusivity. H.R.2212/S.974: CREATES Act of 2017. H.R.6043/S.3335: Fair Accountability and Innovative Research Drug Pricing Act of 2016. S.297: Increasing Competition in Pharmaceuticals Act. H.R.749: Lower Drug Costs through Competition Act. H.R.2430/S.934: FDA Reauthorization Act of 2017. H.R.1223/S.1509: Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017.
Client expense: $660,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
2017 · third_quarter · Medicare/Medicaid
Preventing cuts to Medicare Graduate Medical Education payments: "The Medicare IME Pool Act of 2015" (H.R. 3292); preventing cuts to Disproportionate Share Hospital Payments: "The Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015" (H.R. 3288); Preventing reductions to Hospital Inpatient and Outpatient PPS Payments: "The Medicare Crosswalk Hospital Code Development Act of 2015" (H.R. 3291), Medicare payments for Off-Campus Hospital outpatient departments; implementation of Section 603 "Bipartisan Budget Act of 2015)" (H.R. 1314), "Helping Hospitals Improve Patient Care Act of 2016" (H.R. 5273) 21st Century Cures Act (H.R. 34); CY 2017 Medicare Hospital Outpatient Prospective payment system proposed rule: Provider reimbursements for end of life care counseling; Additional Medicare support for Medicare Graduate Medical Education; Allowing nurse practitioners, certified nurse-midwives, and clinical nurse specialists to certify home health service for Medicare patients: "Home Health Care Planning Improvement Act" (S 578); Medicare payment for short hospital stays; Preventing reductions to the Medicaid program including the provider tax; Improvements to the Medicaid program for medically complex children: "Advancing Care for Exceptional Children Act of 2015" (H.R. 546/S 298).
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · third_quarter · Trade (domestic/foreign)
Trans-Pacific Partnership H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act of 2015 H.R. 1314 Trade Act of 2015 PHIT Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Pharmacy
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2841: FAST Generics Act of 2015. H.R.2051: FAST Generics Act of 2017. S.124: Preserve Access to Affordable Generics Act. H.R.1245/S.469: Affordable and Safe Prescription Drug Importation Act. H.R.1314: Bipartisan Budget Act of 2015. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). H.R.2562/S.1115: Making Pharmaceutical Markets More Competitive Act. S.771: Improving Access To Affordable Prescription Drugs Act. Pharmaceutical Exclusivity. S.3056: CREATES Act of 2016. H.R.2212/S.974: CREATES Act of 2017. H.R.6043/S.3335: Fair Accountability and Innovative Research Drug Pricing Act of 2016. S.297: Increasing Competition in Pharmaceuticals Act. H.R.749: Lower Drug Costs through Competition Act. Drug Importation. H.R.2430/S.934: FDA Reauthorization Act of 2017. FDA Commissioner Nomination.
Client expense: $780,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
2017 · first_quarter · Pharmacy
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2841: FAST Generics Act of 2015. H.R.1314: Bipartisan Budget Act of 2015. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). Pharmaceutical Exclusivity. S.3056: CREATES Act of 2016. H.R.6043/S.3335: Fair Accountability and Innovative Research Drug Pricing Act of 2016. S.297: Increasing Competition in Pharmaceuticals Act. H.R.749: Lower Drug Costs through Competition Act. Drug Importation.
Client expense: $720,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2017 · second_quarter · Trade (domestic/foreign)
H.R.1314 - Trade Act of 2015 United States-Japan beef issues, no specific legislation United States-Korea beef issues, no specific legislation United States-China beef and pork issues, no specific legislation United States-Taiwan beef and pork issues, no specific legislation United States-Russia pork issues, no specific legislation United States-Mexico beef and pork issues, no specific legislation United States-European Union beef issues, no specific legislation Trans-Pacific Partnership negotiations, no specific legislation
Client expense: Not reported · Firm income: $50,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2017 · second_quarter · Medicare/Medicaid
Preventing cuts to Medicare Graduate Medical Education payments: "The Medicare IME Pool Act of 2015" (H.R. 3292); preventing cuts to Disproportionate Share Hospital Payments: "The Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015" (H.R. 3288); Preventing reductions to Hospital Inpatient and Outpatient PPS Payments: "The Medicare Crosswalk Hospital Code Development Act of 2015" (H.R. 3291), Medicare payments for Off-Campus Hospital outpatient departments; implementation of Section 603 "Bipartisan Budget Act of 2015)" (H.R. 1314), "Helping Hospitals Improve Patient Care Act of 2016" (H.R. 5273) 21st Century Cures Act (H.R. 34); CY 2017 Medicare Hospital Outpatient Prospective payment system proposed rule: Provider reimbursements for end of life care counseling; Additional Medicare support for Medicare Graduate Medical Education; Allowing nurse practitioners, certified nurse-midwives, and clinical nurse specialists to certify home health service for Medicare patients: "Home Health Care Planning Improvement Act" (S 578); Medicare payment for short hospital stays; Preventing reductions to the Medicaid program including the provider tax; Improvements to the Medicaid program for medically complex children: "Advancing Care for Exceptional Children Act of 2015" (H.R. 546/S 298).
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · second_quarter · Trade (domestic/foreign)
Trans-Pacific Partnership H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act of 2015 H.R. 1314 Trade Act of 2015 PHIT Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Trade (domestic/foreign)
Trans-Pacific Partnership H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act of 2015 H.R. 1314 Trade Act of 2015 PHIT Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Medicare/Medicaid
Preventing cuts to Medicare Graduate Medical Education payments: "The Medicare IME Pool Act of 2015" (H.R. 3292); preventing cuts to Disproportionate Share Hospital Payments: "The Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015" (H.R. 3288); Preventing reductions to Hospital Inpatient and Outpatient PPS Payments: "The Medicare Crosswalk Hospital Code Development Act of 2015" (H.R. 3291), Medicare payments for Off-Campus Hospital outpatient departments; implementation of Section 603 "Bipartisan Budget Act of 2015)" (H.R. 1314), "Helping Hospitals Improve Patient Care Act of 2016" (H.R. 5273) 21st Century Cures Act (H.R. 34); CY 2017 Medicare Hospital Outpatient Prospective payment system proposed rule: Provider reimbursements for end of life care counseling; Additional Medicare support for Medicare Graduate Medical Education; Allowing nurse practitioners, certified nurse-midwives, and clinical nurse specialists to certify home health service for Medicare patients: "Home Health Care Planning Improvement Act" (S 578); Medicare payment for short hospital stays; Preventing reductions to the Medicaid program including the provider tax; Improvements to the Medicaid program for medically complex children: "Advancing Care for Exceptional Children Act of 2015" (H.R. 546/S 298).
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Pharmacy
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2841: FAST Generics Act of 2015. H.R.1314: Bipartisan Budget Act of 2015. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). Pharmaceutical Exclusivity. S.3056: CREATES Act of 2016. H.R.6043/S.3335: Fair Accountability and Innovative Research Drug Pricing Act of 2016. S.297: Increasing Competition in Pharmaceuticals Act. H.R.749: Lower Drug Costs through Competition Act. Drug Importation.
Client expense: $720,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2017 · first_quarter · Medicare/Medicaid
Preventing cuts to Medicare Graduate Medical Education payments: "The Medicare IME Pool Act of 2015" (H.R. 3292); preventing cuts to Disproportionate Share Hospital Payments: "The Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015" (H.R. 3288); Preventing reductions to Hospital Inpatient and Outpatient PPS Payments: "The Medicare Crosswalk Hospital Code Development Act of 2015" (H.R. 3291), Medicare payments for Off-Campus Hospital outpatient departments; implementation of Section 603 "Bipartisan Budget Act of 2015)" (H.R. 1314), "Helping Hospitals Improve Patient Care Act of 2016" (H.R. 5273) 21st Century Cures Act (H.R. 34); CY 2017 Medicare Hospital Outpatient Prospective payment system proposed rule: Provider reimbursements for end of life care counseling; Additional Medicare support for Medicare Graduate Medical Education; Allowing nurse practitioners, certified nurse-midwives, and clinical nurse specialists to certify home health service for Medicare patients: "Home Health Care Planning Improvement Act" (S 578); Medicare payment for short hospital stays; Preventing reductions to the Medicaid program including the provider tax; Improvements to the Medicaid program for medically complex children: "Advancing Care for Exceptional Children Act of 2015" (H.R. 546/S 298).
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Trade (domestic/foreign)
H.R.1314 - Trade Act of 2015 Priorities and Accountability Act of 2015 United States-Japan beef issues, no specific legislation United States-Korea beef issues, no specific legislation United States-China beef and pork issues, no specific legislation United States-Taiwan beef and pork issues, no specific legislation United States-Russia pork issues, no specific legislation United States-Mexico beef and pork issues, no specific legislation Trans-Pacific Partnership negotiations, no specific legislation
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2016 · third_quarter · Taxation/Internal Revenue Code
Tax reform; H.R. 1314, Bipartisan Budget Act of 2015; H.R. 2029, Protecting Americans from Tax Hikes Act; H.R. 3431, Waterway LNG Parity Act of 2015
Client expense: Not reported · Firm income: $80,000
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Natl Security Council (NSC), SENATE, White House Office
2016 · second_quarter · Trade (domestic/foreign)
H.R.1057 - Parts Act H.R.1314 - Trade Act 2015 S.560 - Parts Acts
Client expense: $2,200,000 · Firm income: Not reported
Government targets: Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Research & Special Programs Administration, SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office
2016 · third_quarter · Budget/Appropriations
Fiscal Year 2016 Budget and Appropriations Fiscal Year 2017 Appropriations Site-neutral provisions of HR1314
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2841: FAST Generics Act of 2015. H.R.1314: Bipartisan Budget Act of 2015. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). Pharmaceutical exclusivity. S.3056: CREATES Act of 2016. H.R.6: 21st Century Cures Act.
Client expense: $950,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2016 · third_quarter · Pharmacy
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2841: FAST Generics Act of 2015. H.R.1314: Bipartisan Budget Act of 2015. Drug Importation. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). S.2615: Increasing Competition in Pharmaceuticals Act. Pharmaceutical exclusivity. H.R.4931: Pharmaceutical Stewardship Act of 2016. H.R.953: Comprehensive Addiction and Recovery Act of 2015 (CARA). S.3056: CREATES Act of 2016.
Client expense: $570,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Pharmacy
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2841: FAST Generics Act of 2015. H.R.1314: Bipartisan Budget Act of 2015. Drug Importation. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). S.2615: Increasing Competition in Pharmaceuticals Act. Pharmaceutical exclusivity. H.R.4931: Pharmaceutical Stewardship Act of 2016. H.R.953: Comprehensive Addiction and Recovery Act of 2015 (CARA). S.3056: CREATES Act of 2016.
Client expense: $800,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2016 · second_quarter · Budget/Appropriations
FDA Funding. S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.1314: Bipartisan Budget Act of 2015. S.2837: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017. S.3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017. H.R.3020: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016.
Client expense: $800,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2016 · second_quarter · Medicare/Medicaid
Medicare Part D Program and Generic Drugs. Medicare reimbursement for biosimilars. H.R.1314: Bipartisan Budget Act of 2015. Covered Outpatient Drugs (CMS-2345-FC). CMMI Part B Drug Demo.
Client expense: $800,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2016 · third_quarter · Pharmacy
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2841: FAST Generics Act of 2015. H.R.1314: Bipartisan Budget Act of 2015. Drug Importation. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). S.2615: Increasing Competition in Pharmaceuticals Act. Pharmaceutical exclusivity. H.R.4931: Pharmaceutical Stewardship Act of 2016. H.R.953: Comprehensive Addiction and Recovery Act of 2015 (CARA). S.3056: CREATES Act of 2016.
Client expense: $569,598 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Budget/Appropriations
H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 5325 - Continuing Appropriations H.R. 2028 - Further Continuing and Security Assitance Appropriations Act, 2017
Client expense: $80,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Budget/Appropriations
Discussed Medicaid, Medicare proposals, and Older Americans Act; H.R. 2029, Consolidated Appropriations Act of 2016 - Lobbied to protect funding and in opposition to any policy riders to Affordable Health Care Act and related health care programs; H.Con.Res. 27/ S.Con.Res.11 - Protect end of life for seniors; HR 1314, Bipartisan Budget Act of 2015 - Lobbied to protect funding related to seniors programs, including lobbying to reallocate Old-Age, Survivors, and Disability Insurance (OASDI) funding to Social Security Disability Insurance (SSDI) trust funds without imposing barriers to claims processing or reduction of benefits.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Discussed Medicaid, Medicare proposals, and Older Americans Act; H.R. 2029, Consolidated Appropriations Act of 2016 - Lobbied to protect funding and in opposition to any policy riders to Affordable Health Care Act and related health care programs; H.Con.Res. 27/ S.Con.Res.11 - Protect end of life for seniors; HR 1314, Bipartisan Budget Act of 2015 - Lobbied to protect funding related to seniors programs, including lobbying to reallocate Old-Age, Survivors, and Disability Insurance (OASDI) funding to Social Security Disability Insurance (SSDI) trust funds without imposing barriers to claims processing or reduction of benefits.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Health Issues
Discussed Medicaid, Medicare proposals, and Older Americans Act; H.R. 2029, Consolidated Appropriations Act of 2016 - Lobbied to protect funding and in opposition to any policy riders to Affordable Health Care Act and related health care programs; H.Con.Res. 27/ S.Con.Res.11 - Protect end of life for seniors; HR 1314, Bipartisan Budget Act of 2015 - Lobbied to protect funding related to seniors programs, including lobbying to reallocate Old-Age, Survivors, and Disability Insurance (OASDI) funding to Social Security Disability Insurance (SSDI) trust funds without imposing barriers to claims processing or reduction of benefits.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Taxation/Internal Revenue Code
Discussed Medicaid, Medicare proposals, and Older Americans Act; H.R. 2029, Consolidated Appropriations Act of 2016 - Lobbied to protect funding and in opposition to any policy riders to Affordable Health Care Act and related health care programs; H.Con.Res. 27/ S.Con.Res.11 - Protect end of life for seniors; HR 1314, Bipartisan Budget Act of 2015 - Lobbied to protect funding related to seniors programs, including lobbying to reallocate Old-Age, Survivors, and Disability Insurance (OASDI) funding to Social Security Disability Insurance (SSDI) trust funds without imposing barriers to claims processing or reduction of benefits.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Issues related to a Medicaid rebate for generic drugs, including provisions in the Bipartisan Budget Act of 2015 (H.R. 1314).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Medicare/Medicaid
Physician and pharmacy reimbursement issues H.R. 696 To amend Part B of title XVII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare H.R. 1416 Cancer Patient Protection Act of 2015 H.R. 2895, the Medicare Patient Access to Cancer Treatment Act H.R. 1314, Bipartisan Budget Act of 2015 Medicare Part B Drug Payment Model Proposed Rule
Client expense: $340,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Taxation/Internal Revenue Code
Carried Interest/Enterprise Value Regulation of passive investment in U.S. securities and other assets by non-U.S. investors. Tax reform in non-U.S. jurisdictions. Pending legislation on international tax reform. Management and Control Unrelated Business Income Tax (UBIT) Legislative oversight of implementation of rules under 871(m) of the Tax Code. Oversight of 305(c) Implementation H.R. 2889 - To amend the Internal Revenue Code of 1986 to provide for the proper tax treatment of personal service income earned in pass-thru entities. S.1686 - To amend the Internal Revenue Code of 1986 to provide for the proper tax treatment of personal service income earned in pass-thru entities. H.R. 1314 - the Bipartisan Budget Act of 2015 - To amend the Internal Revenue Code of 1986 to provide for a right to an administrative appeal relating to adverse determinations of tax-exempt status of certain organizations. (partnership audit provisions) An Amendment to H.R. 2029 - the Consolidated Appropriations Act, 2016 (omnibus appropriations - partnership audit provisions) OECD BEPS Tax Treaty Project. H.R.6439 - the Tax Technical Corrections Act of 2016
Client expense: $920,000 · Firm income: Not reported
Government targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
2016 · fourth_quarter · Budget/Appropriations
HR 1314: Bipartisan Budget Act of 2015; provisions related to energy
Client expense: $3,000,000 · Firm income: Not reported
Government targets: Army, Dept of (Corps of Engineers), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), White House Office
2016 · fourth_quarter · Financial Institutions/Investments/Securities
H.R. 50 (Unfunded Mandates Information and Transparency Act of 2015); H.R. 414 (Burdensome Data Collection Relief Act); H.R. 644 (Trade Facilitation and Trade Enforcement Act of 2015); H.R. 1090 (Retail Investor Protection Act); H.R. 1098 (Investor Choice Act of 2015); H.R. 1163 (Futures Investor Protection Act); H.R. 1295 (Trade Preferences Extension Act of 2015); H.R. 1314 (Trade Act of 2015); H.R. 1334 (Holding Company Registration Threshold Equalization Act of 2015); H.R. 1525 (Disclosure Modernization and Simplification Act of 2015); H.R. 1550 (Financial Stability Oversight Council Improvement Act of 2015); H.R. 1723 (Small Company Simple Registration Act of 2015); H.R. 1890 (Bipartisan Congressional Trade Priorities and Accountability Act of 2015); H.R. 1982 (Restoring Main Street Investor Protection and Confidence Act); H.R. 2356 (Fair Access to Investment Research Act of 2015); H.R. 3738 (Office of Financial Research Accountability Act of 2015); H.R. 3340 (Financial Stability Oversight Council Reform Act); H.R. 4538 (Senior$afe Act of 2016); H.R. 5019 (Fair Access to Investment Research Act of 2016); H.R. 5485 (Financial Services and General Government Appropriations Act, 2017); H.R. 5592 (Derivatives Oversight and Taxpayer Protection Act); S. 67 (Restoring Main Street Investor Protection and Confidence Act); S. 115 (Fair Tax Act of 2015); S. 153 (I-Squared Act of 2015); S. 161 (Paying a Fair Share Act of 2015); S. 305 (American Job Protection Act); S. 576 (Encouraging Employee Ownership Act); S. 995 (Bipartisan Congressional Trade Priorities and Accountability Act of 2015); S. 1484 (Financial Regulatory Improvement Act of 2015); S. 2216 (Senior$afe Act of 2015); S. 2497 (Retail Investor Protection Act of 2016); S. 3092 (Fair Access to Investment Research Act of 2016); Swap dealer and major swap participant recordkeeping and reporting, duties, and conflicts of interest policies and procedures; Swap execution facilities; Swap dealer, major swap participant, and futures commission merchant chief compliance officer; Dodd-Frank Wall Street Reform and Consumer Protection Act Implementation (including Section 913; Section 914; Systemic risk regulation and liquidation authority; Section 342 (Office of Minority and Women Inclusion); Section 621; Section 941; Title I and Title II); Systemic Risk Regulation and liquidation authority; China - strategic and economic dialogue; Bilateral Investment Treaties, India, China; Transpacific Partnership; India Market Access Issues; European Union proposal regarding Credit Default Swaps and Credit Rating Agencies and their impact on US Markets; Basel Capital Rules; Basel Securitization Framework; TransAtlantic Trade and Investment Partnership (TTIP); India Financial Sector Reform; Accounting standards for municipalities; Securities Investor Protection Corporation (SIPC) reform and funding fees; Support of financial literacy; Privacy and cybersecurity issues (general); Municipal advisor regulation; CFTC cross-border guidance exemptive order; Financial Stability Oversight Council (FSOC); FSOC consideration of systemically important financial institutions (SIFIs); FSOC Transparency Policy; CFTC exemptive order on extraterritorial scope of Title VII; Legal entity identifier (LEI); Jumpstart our Business Startups (JOBS) Act implementation; Basel Committee on Banking Supervision (BCBS) and International Organization of Securities Commissions (IOSCO) consultation paper on margin requirements for uncleared derivatives; Commodity Pools and Securitization; Securities and Exchange Commission Rules 15Ba1-1 through 15Ba1-8; CFTC recordkeeping requirements (CEA Section 23.201); Leverage capital requirements; Release No. 34-71958, Security-Based Swap Dealers Recordkeeping; Recordkeeping Requirements; Rules 17a-3, 17a-4 (Securities and Exchange Commission, Commodity Futures Trading Commission, Financial Industry Regulatory Authority); Regulation AB II (asset backed securities - Securities and Exchange Commission, Consumer Financial Protection Bureau); CFTC proposed rule on margin requirements for uncleared swaps; Prudential Regulator's proposed rule on margin requirements for uncleared swaps; Futures Commission Merchant and Introducing Broker Conflicts of Interest Policies and Procedures; Inter-affiliate swap transactions; Securities and Exchange Commission proposed rule on margin requirements for uncleared swaps; U.S./EU cross-border regulatory issues; Trade policy issues (general); China "Secure and Controllable" information and communication technologies (ICT) regulations. Mutual Fund 12b-1 Fees; Senior investors/diminished capacity investors; Broker-dealers/investment advisers mitigation of accounts; Public Company Accounting Oversight Board small broker/dealer exemption; U.S./EU financial markets regulatory dialogue; Trade and international issues (general); Diversity (general); National Market System (NMS) discussion draft; Data localization requirements in the Trans-Pacific Partnership; Swap Execution Facilities (SEFs) and clearing for swaps; Global FX Code of Conduct; Decision to delay implementation for margin for non-centrally cleared swaps; Financial CHOICE Act.
Client expense: $2,560,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Executive Office of the President (EOP), Federal Deposit Insurance Corporation (FDIC), Federal Housing Finance Agency (FHFA), Federal Reserve System, Ginnie Mae, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Credit Union Administration (NCUA), Natl Economic Council (NEC), Natl Security Council (NSC), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2016 · fourth_quarter · Trade (domestic/foreign)
HR 1314 Trade Act of 2015; HR 1773 Residue Entries and Streamlining Trade Act; HR 4909 National Defense Authorization Act for Fiscal Year 2017, provisions related to LNG exports; HR 644 An act to reauthorize trade facilitation and trade enforcement functions and activities, and for other purposes; S 2012 Energy Policy Modernization Act, provisions related to LNG exports; S 989 Residue Entries and Streamlining Trade Act; S 995 Bipartisan Congressional Trade Priorities and Accountability Act.
Client expense: $1,620,000 · Firm income: Not reported
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, White House Office
2016 · fourth_quarter · Budget/Appropriations
budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 H.R. 5325 - Continuing Appropriations H.R. 2028 - Further Continuing and Security Assistance Appropriations Act, 2017
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Taxation/Internal Revenue Code
H.R. 1314, Bipartisan Budget Act of 2015: partnership audit rules.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Treasury, Dept of
2016 · fourth_quarter · Budget/Appropriations
Presidents Budget, FY 2017 S. 3040/H.R. 5916 Labor, HHS, Education and Related Agencies Act, 2017, Title II Issues: Support funding for National Institutes of Health (NIH), Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Childrens Hospitals Graduate Medical Education (CHGME), Health Resources and Services Administration (HRSA), the Prevention and Public Health Fund (PPHF), Hospital Preparedness Program, and biodefense and public health preparedness programs. Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. Oppose rescissions from the Center for Medicare and Medicaid Innovation and Patient Centered Outcomes Research Trust Fund. Oppose additional continuing resolutions. President's Budget, FY 2017 Issues: Oppose proposed reductions in Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments; oppose use of Medicare GME funding for creation of new GME grant program. Oppose Independent Payment Advisory Panel (IPAB) and site-neutral payment policy. President's Budget, FY 2017 P.L. 114-223 Continuing Appropriations and Military Construction, Veterans Affairs, and Related Appropriations Act, 2017, and Zika Preparedness Act Issues: Support funding for Veterans Affairs medical research, research infrastructure, and community care. S. 289/H.R. 2104, American Cures Act Issue: Increases budget authority for National Institutes of Health (NIH), Center for Disease Control and Prevention, Department of Defense Health Program, and the VA Medical and Prosthetics Research Program S. 318/H.R. 531, Accelerating Biomedical Research Act Issue: Increases discretionary spending cap to increase funding for the National Institutes of Health (NIH). H.R. 777, Permanent Investment in Health Research Act Issue: Creates mandatory appropriation for the National Institutes of Health (NIH), adjusted annually for inflation. S. 2624, National Biomedical Research Act. Issue: Support establishment of a Biomedical Innovation Fund to support the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending. P.L. 114-74, H.R. 1314, Bipartisan Budget Act of 2015 Issue: Oppose Medicare site-neutral payment policy. Oppose extension of Medicare sequester Issue: Support mandatory funding for the National Health Service Corps (NHSC) authorized under P.L. 114-10, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) P.L. 114-223 Continuing Appropriations and Military Construction, Veterans Affairs, and Related Appropriations Act, 2017, and Zika Preparedness Act Issue: Support supplemental funding to prevent and combat Zika virus; Oppose use of other health funding to offset Zika investments
Client expense: $687,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
2016 · fourth_quarter · Transportation
H.R.22, Developing a Reliable and Innovative Vision for the Economy Act- An act to authorize funds for Federal-aid highways, highway safety programs, and transit programs, and for other purposes. (Sec 5223, Sec 11415, Sec 32205) H.R.1314, Bipartisan Budget Act of 2015- To amend the Internal Revenue Code of 1986 to provide for a right to an administrative appeal relating to adverse determinations of tax-exempt status of certain organizations. (Sec 201) Issues related to the commercial operation of unmanned aerial/vehicles (drones)
Client expense: $390,000 · Firm income: Not reported
Government targets: Federal Emergency Management Agency (FEMA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of
2016 · fourth_quarter · Budget/Appropriations
Bipartisan Budget Act (H.R. 1314) FY2017 budget H.R. 2028, continuing resolution Reconciliation (H.R. 3762) Medicare Sequestration Hospital Preparedness Program funding (H.R. 3299) Graduate Medical Education funding National Institutes of Health funding (H.R. 34 - 21st Century Cures Act) Childrens Health Insurance Program Trauma funding Opioid funding (H.R. 34 - 21st Century Cures Act)
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Budget/Appropriations
budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 5325 - Continuing Appropriations H.R. 2028 - Further Continuing and Security Assistance Appropriations Act, 2017
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE